SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'DZW'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DB1_A_VDXA428_1 (VITAMIN D NUCLEARRECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 5 / 12 | LEU A 261SER A 265SER A 306CYH A 316LEU A 419 | DZW A 501 ( 4.5A)DZW A 501 (-3.0A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)None | 1.31A | 1db1A-6fobA:37.2 | 1db1A-6fobA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DB1_A_VDXA428_1 (VITAMIN D NUCLEARRECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 9 / 12 | TYR A 175LEU A 258LEU A 261SER A 265SER A 303SER A 306CYH A 316VAL A 328LEU A 337 | NoneDZW A 501 (-3.8A)DZW A 501 ( 4.5A)DZW A 501 (-3.0A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)DZW A 501 ( 4.3A)None | 0.70A | 1db1A-6fobA:37.2 | 1db1A-6fobA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DB1_A_VDXA428_1 (VITAMIN D NUCLEARRECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 6 / 12 | TYR A 175LEU A 261VAL A 262SER A 265SER A 303LEU A 338 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)None | 1.24A | 1db1A-6fobA:37.2 | 1db1A-6fobA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DB1_A_VDXA428_1 (VITAMIN D NUCLEARRECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 11 / 12 | TYR A 175LEU A 261VAL A 262SER A 265SER A 303SER A 306CYH A 316VAL A 328HIS A 333LEU A 337HIS A 423 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)DZW A 501 ( 4.3A)DZW A 501 (-3.9A)NoneDZW A 501 (-4.0A) | 0.31A | 1db1A-6fobA:37.2 | 1db1A-6fobA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DB1_A_VDXA428_1 (VITAMIN D NUCLEARRECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 6 / 12 | TYR A 175LEU A 261VAL A 262SER A 303LEU A 338HIS A 333 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.8A)NoneDZW A 501 (-3.9A) | 1.47A | 1db1A-6fobA:37.2 | 1db1A-6fobA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DB1_A_VDXA428_1 (VITAMIN D NUCLEARRECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 8 / 12 | TYR A 175LEU A 261VAL A 262SER A 303SER A 306CYH A 316LEU A 337HIS A 333 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)NoneDZW A 501 (-3.9A) | 1.49A | 1db1A-6fobA:37.2 | 1db1A-6fobA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DB1_A_VDXA428_2 (VITAMIN D NUCLEARRECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 6 / 6 | LEU A 255ILE A 299ARG A 302TRP A 314TYR A 323VAL A 444 | NoneDZW A 501 (-4.7A)DZW A 501 (-3.8A)DZW A 501 (-3.5A)DZW A 501 (-3.6A)None | 0.28A | 1db1A-6fobA:37.2 | 1db1A-6fobA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IE9_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 9 / 12 | TYR A 175LEU A 258LEU A 261SER A 265SER A 303SER A 306CYH A 316VAL A 328LEU A 341 | NoneDZW A 501 (-3.8A)DZW A 501 ( 4.5A)DZW A 501 (-3.0A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)DZW A 501 ( 4.3A)None | 0.81A | 1ie9A-6fobA:37.3 | 1ie9A-6fobA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IE9_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 11 / 12 | TYR A 175LEU A 261VAL A 262SER A 265SER A 303SER A 306CYH A 316VAL A 328HIS A 333LEU A 341HIS A 423 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)DZW A 501 ( 4.3A)DZW A 501 (-3.9A)NoneDZW A 501 (-4.0A) | 0.36A | 1ie9A-6fobA:37.3 | 1ie9A-6fobA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IE9_A_VDXA500_2 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 4 / 4 | LEU A 255ILE A 299ARG A 302TRP A 314 | NoneDZW A 501 (-4.7A)DZW A 501 (-3.8A)DZW A 501 (-3.5A) | 0.32A | 1ie9A-6fobA:37.3 | 1ie9A-6fobA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RK3_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 6 / 12 | LEU A 261SER A 265SER A 306TRP A 314CYH A 316LEU A 419 | DZW A 501 ( 4.5A)DZW A 501 (-3.0A)DZW A 501 (-2.7A)DZW A 501 (-3.5A)DZW A 501 (-3.4A)None | 1.43A | 1rk3A-6fobA:38.9 | 1rk3A-6fobA:21.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RK3_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 5 / 12 | LEU A 261VAL A 262SER A 303LEU A 338HIS A 333 | DZW A 501 ( 4.5A)NoneDZW A 501 (-3.8A)NoneDZW A 501 (-3.9A) | 1.35A | 1rk3A-6fobA:38.9 | 1rk3A-6fobA:21.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RK3_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 6 / 12 | TYR A 175LEU A 261VAL A 262SER A 265SER A 303LEU A 338 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)None | 1.30A | 1rk3A-6fobA:38.9 | 1rk3A-6fobA:21.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RK3_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 12 / 12 | TYR A 175LEU A 261VAL A 262SER A 265SER A 303SER A 306TRP A 314CYH A 316VAL A 328HIS A 333LEU A 337HIS A 423 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.5A)DZW A 501 (-3.4A)DZW A 501 ( 4.3A)DZW A 501 (-3.9A)NoneDZW A 501 (-4.0A) | 0.27A | 1rk3A-6fobA:38.9 | 1rk3A-6fobA:21.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RK3_A_VDXA500_2 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 4 / 4 | LEU A 255ILE A 299ARG A 302TYR A 427 | NoneDZW A 501 (-4.7A)DZW A 501 (-3.8A)DZW A 501 (-4.9A) | 0.12A | 1rk3A-6fobA:38.9 | 1rk3A-6fobA:21.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S19_A_MC9A500_0 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 12 / 12 | LEU A 255LEU A 261VAL A 262ILE A 299SER A 303SER A 306TRP A 314CYH A 316TYR A 323VAL A 328LEU A 337LEU A 341 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-4.7A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.5A)DZW A 501 (-3.4A)DZW A 501 (-3.6A)DZW A 501 ( 4.3A)NoneNone | 0.30A | 1s19A-6fobA:37.4 | 1s19A-6fobA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S19_A_MC9A500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 5 / 5 | TYR A 175SER A 265ARG A 302HIS A 333HIS A 423 | NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)DZW A 501 (-3.9A)DZW A 501 (-4.0A) | 0.17A | 1s19A-6fobA:37.4 | 1s19A-6fobA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HC4_A_VDXA525_1 (VITAMIN D RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 6 / 12 | PHE A 182LEU A 261SER A 265SER A 306CYH A 316LEU A 419 | NoneDZW A 501 ( 4.5A)DZW A 501 (-3.0A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)None | 1.33A | 2hc4A-6fobA:41.3 | 2hc4A-6fobA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HC4_A_VDXA525_1 (VITAMIN D RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 8 / 12 | PHE A 185LEU A 261VAL A 262SER A 265VAL A 328HIS A 333LEU A 337HIS A 423 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 ( 4.3A)DZW A 501 (-3.9A)NoneDZW A 501 (-4.0A) | 1.32A | 2hc4A-6fobA:41.3 | 2hc4A-6fobA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HC4_A_VDXA525_1 (VITAMIN D RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 6 / 12 | TYR A 175PHE A 182LEU A 261VAL A 262LEU A 338HIS A 333 | NoneNoneDZW A 501 ( 4.5A)NoneNoneDZW A 501 (-3.9A) | 1.43A | 2hc4A-6fobA:41.3 | 2hc4A-6fobA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HC4_A_VDXA525_1 (VITAMIN D RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 6 / 12 | TYR A 175PHE A 182LEU A 261VAL A 262SER A 265LEU A 338 | NoneNoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)None | 1.12A | 2hc4A-6fobA:41.3 | 2hc4A-6fobA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HC4_A_VDXA525_1 (VITAMIN D RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 12 / 12 | TYR A 175PHE A 182LEU A 261VAL A 262SER A 265SER A 306CYH A 316VAL A 328HIS A 333LEU A 337HIS A 423LEU A 430 | NoneNoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)DZW A 501 ( 4.3A)DZW A 501 (-3.9A)NoneDZW A 501 (-4.0A)None | 0.20A | 2hc4A-6fobA:41.3 | 2hc4A-6fobA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HC4_A_VDXA525_2 (VITAMIN D RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 6 / 7 | LEU A 255ILE A 299ARG A 302SER A 303TRP A 314TYR A 427 | NoneDZW A 501 (-4.7A)DZW A 501 (-3.8A)DZW A 501 (-3.8A)DZW A 501 (-3.5A)DZW A 501 (-4.9A) | 0.20A | 2hc4A-6fobA:41.3 | 2hc4A-6fobA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HC4_A_VDXA525_2 (VITAMIN D RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 5 / 7 | LEU A 255LEU A 258ARG A 302SER A 303TRP A 314 | NoneDZW A 501 (-3.8A)DZW A 501 (-3.8A)DZW A 501 (-3.8A)DZW A 501 (-3.5A) | 0.89A | 2hc4A-6fobA:41.3 | 2hc4A-6fobA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZLC_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 5 / 12 | LEU A 261SER A 265SER A 306CYH A 316LEU A 419 | DZW A 501 ( 4.5A)DZW A 501 (-3.0A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)None | 1.31A | 2zlcA-6fobA:38.9 | 2zlcA-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZLC_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 5 / 12 | LEU A 261VAL A 262SER A 303LEU A 338HIS A 333 | DZW A 501 ( 4.5A)NoneDZW A 501 (-3.8A)NoneDZW A 501 (-3.9A) | 1.33A | 2zlcA-6fobA:38.9 | 2zlcA-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZLC_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 6 / 12 | TYR A 175LEU A 261VAL A 262SER A 265SER A 303LEU A 338 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)None | 1.26A | 2zlcA-6fobA:38.9 | 2zlcA-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZLC_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 12 / 12 | TYR A 175LEU A 261VAL A 262SER A 265SER A 303SER A 306CYH A 316VAL A 328HIS A 333LEU A 337HIS A 423LEU A 430 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)DZW A 501 ( 4.3A)DZW A 501 (-3.9A)NoneDZW A 501 (-4.0A)None | 0.34A | 2zlcA-6fobA:38.9 | 2zlcA-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZLC_A_VDXA500_2 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 5 / 5 | LEU A 255ILE A 299ARG A 302TRP A 314TYR A 427 | NoneDZW A 501 (-4.7A)DZW A 501 (-3.8A)DZW A 501 (-3.5A)DZW A 501 (-4.9A) | 0.19A | 2zlcA-6fobA:38.9 | 2zlcA-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M7R_A_VDXA425_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 7 / 12 | TYR A 175LEU A 258LEU A 261SER A 303SER A 306CYH A 316VAL A 328 | NoneDZW A 501 (-3.8A)DZW A 501 ( 4.5A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)DZW A 501 ( 4.3A) | 0.84A | 3m7rA-6fobA:37.4 | 3m7rA-6fobA:22.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M7R_A_VDXA425_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 9 / 12 | TYR A 175LEU A 261VAL A 262SER A 303SER A 306CYH A 316VAL A 328LEU A 337HIS A 423 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)DZW A 501 ( 4.3A)NoneDZW A 501 (-4.0A) | 0.24A | 3m7rA-6fobA:37.4 | 3m7rA-6fobA:22.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M7R_A_VDXA425_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 9 / 12 | TYR A 175VAL A 262SER A 265SER A 303SER A 306CYH A 316VAL A 328LEU A 337HIS A 423 | NoneNoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.4A)DZW A 501 ( 4.3A)NoneDZW A 501 (-4.0A) | 0.60A | 3m7rA-6fobA:37.4 | 3m7rA-6fobA:22.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M7R_A_VDXA425_2 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 9 / 9 | PHE A 182LEU A 255ILE A 299ARG A 302TRP A 314TYR A 323LEU A 341TYR A 427VAL A 444 | NoneNoneDZW A 501 (-4.7A)DZW A 501 (-3.8A)DZW A 501 (-3.5A)DZW A 501 (-3.6A)NoneDZW A 501 (-4.9A)None | 0.36A | 3m7rA-6fobA:37.4 | 3m7rA-6fobA:22.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M7R_A_VDXA425_2 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 5 / 9 | PHE A 182TYR A 323LEU A 338TYR A 427VAL A 444 | NoneDZW A 501 (-3.6A)NoneDZW A 501 (-4.9A)None | 1.48A | 3m7rA-6fobA:37.4 | 3m7rA-6fobA:22.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VT3_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 6 / 12 | LEU A 261SER A 265SER A 306TRP A 314CYH A 316LEU A 419 | DZW A 501 ( 4.5A)DZW A 501 (-3.0A)DZW A 501 (-2.7A)DZW A 501 (-3.5A)DZW A 501 (-3.4A)None | 1.44A | 3vt3A-6fobA:38.3 | 3vt3A-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VT3_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 5 / 12 | LEU A 261VAL A 262SER A 303LEU A 338HIS A 333 | DZW A 501 ( 4.5A)NoneDZW A 501 (-3.8A)NoneDZW A 501 (-3.9A) | 1.33A | 3vt3A-6fobA:38.3 | 3vt3A-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VT3_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 6 / 12 | TYR A 175LEU A 261VAL A 262SER A 265SER A 303LEU A 338 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)None | 1.30A | 3vt3A-6fobA:38.3 | 3vt3A-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VT3_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 12 / 12 | TYR A 175LEU A 261VAL A 262SER A 265SER A 303SER A 306TRP A 314CYH A 316VAL A 328HIS A 333LEU A 337HIS A 423 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.5A)DZW A 501 (-3.4A)DZW A 501 ( 4.3A)DZW A 501 (-3.9A)NoneDZW A 501 (-4.0A) | 0.30A | 3vt3A-6fobA:38.3 | 3vt3A-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VT7_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 5 / 12 | LEU A 261VAL A 262SER A 303LEU A 338HIS A 333 | DZW A 501 ( 4.5A)NoneDZW A 501 (-3.8A)NoneDZW A 501 (-3.9A) | 1.31A | 3vt7A-6fobA:36.5 | 3vt7A-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VT7_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 7 / 12 | TYR A 175LEU A 261VAL A 262SER A 265ARG A 302SER A 303LEU A 338 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)DZW A 501 (-3.8A)None | 1.18A | 3vt7A-6fobA:36.5 | 3vt7A-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VT7_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 11 / 12 | TYR A 175LEU A 261VAL A 262SER A 265ARG A 302SER A 303SER A 306VAL A 328HIS A 333LEU A 337HIS A 423 | NoneDZW A 501 ( 4.5A)NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 ( 4.3A)DZW A 501 (-3.9A)NoneDZW A 501 (-4.0A) | 0.26A | 3vt7A-6fobA:36.5 | 3vt7A-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VT7_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 11 / 12 | TYR A 175TYR A 179VAL A 262SER A 265ARG A 302SER A 303SER A 306VAL A 328HIS A 333LEU A 337HIS A 423 | NoneDZW A 501 ( 4.8A)NoneDZW A 501 (-3.0A)DZW A 501 (-3.8A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 ( 4.3A)DZW A 501 (-3.9A)NoneDZW A 501 (-4.0A) | 0.62A | 3vt7A-6fobA:36.5 | 3vt7A-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VT7_A_VDXA500_2 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 4 / 4 | LEU A 255ILE A 299TYR A 323TYR A 427 | NoneDZW A 501 (-4.7A)DZW A 501 (-3.6A)DZW A 501 (-4.9A) | 0.42A | 3vt7A-6fobA:36.5 | 3vt7A-6fobA:21.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RUJ_A_VDXA501_1 (VITAMIN D3 RECEPTORA) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 12 / 12 | TYR A 175VAL A 262SER A 265ILE A 299ARG A 302SER A 303SER A 306TRP A 314CYH A 316VAL A 328HIS A 333HIS A 423 | NoneNoneDZW A 501 (-3.0A)DZW A 501 (-4.7A)DZW A 501 (-3.8A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.5A)DZW A 501 (-3.4A)DZW A 501 ( 4.3A)DZW A 501 (-3.9A)DZW A 501 (-4.0A) | 0.23A | 4rujA-6fobA:41.0 | 4rujA-6fobA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RUJ_A_VDXA501_1 (VITAMIN D3 RECEPTORA) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 7 / 12 | TYR A 175VAL A 262SER A 303SER A 306TRP A 314CYH A 316HIS A 333 | NoneNoneDZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.5A)DZW A 501 (-3.4A)DZW A 501 (-3.9A) | 1.32A | 4rujA-6fobA:41.0 | 4rujA-6fobA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5H1E_A_VDXA501_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 8 / 12 | PHE A 185LEU A 261SER A 265ILE A 299ARG A 302VAL A 328HIS A 333HIS A 423 | NoneDZW A 501 ( 4.5A)DZW A 501 (-3.0A)DZW A 501 (-4.7A)DZW A 501 (-3.8A)DZW A 501 ( 4.3A)DZW A 501 (-3.9A)DZW A 501 (-4.0A) | 1.29A | 5h1eA-6fobA:38.0 | 5h1eA-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5H1E_A_VDXA501_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 12 / 12 | TYR A 175PHE A 182LEU A 261SER A 265ILE A 299ARG A 302SER A 303SER A 306TRP A 314VAL A 328HIS A 333HIS A 423 | NoneNoneDZW A 501 ( 4.5A)DZW A 501 (-3.0A)DZW A 501 (-4.7A)DZW A 501 (-3.8A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.5A)DZW A 501 ( 4.3A)DZW A 501 (-3.9A)DZW A 501 (-4.0A) | 0.34A | 5h1eA-6fobA:38.0 | 5h1eA-6fobA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5H1E_A_VDXA501_1 (VITAMIN D3 RECEPTOR) |
6fob | VITAMIN D3 RECEPTORA (Daniorerio) | 7 / 12 | TYR A 175PHE A 182LEU A 261SER A 303SER A 306TRP A 314HIS A 333 | NoneNoneDZW A 501 ( 4.5A)DZW A 501 (-3.8A)DZW A 501 (-2.7A)DZW A 501 (-3.5A)DZW A 501 (-3.9A) | 1.15A | 5h1eA-6fobA:38.0 | 5h1eA-6fobA:21.78 |